Microscopic colitis
Open Access
- 1 January 2012
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (43), 6206-6215
- https://doi.org/10.3748/wjg.v18.i43.6206
Abstract
Microscopic colitis may be defined as a clinical syndrome, of unknown etiology, consisting of chronic watery diarrhea, with no alterations in the large bowel at the endoscopic and radiologic evaluation. Therefore, a definitive diagnosis is only possible by histological analysis. The epidemiological impact of this disease has become increasingly clear in the last years, with most data coming from Western countries. Microscopic colitis includes two histological subtypes [collagenous colitis (CC) and lymphocytic colitis (LC)] with no differences in clinical presentation and management. Collagenous colitis is characterized by a thickening of the subepithelial collagen layer that is absent in LC. The main feature of LC is an increase of the density of intra-epithelial lymphocytes in the surface epithelium. A number of pathogenetic theories have been proposed over the years, involving the role of luminal agents, autoimmunity, eosinophils, genetics (human leukocyte antigen), biliary acids, infections, alterations of pericryptal fibroblasts, and drug intake; drugs like ticlopidine, carbamazepine or ranitidine are especially associated with the development of LC, while CC is more frequently linked to cimetidine, non-steroidal antiinflammatory drugs and lansoprazole. Microscopic colitis typically presents as chronic or intermittent watery diarrhea, that may be accompanied by symptoms such as abdominal pain, weight loss and incontinence. Recent evidence has added new pharmacological options for the treatment of microscopic colitis: the role of steroidal therapy, especially oral budesonide, has gained relevance, as well as immunosuppressive agents such as azathioprine and 6-mercaptopurine. The use of anti-tumor necrosis factor-α agents, infliximab and adalimumab, constitutes a new, interesting tool for the treatment of microscopic colitis, but larger, adequately designed studies are needed to confirm existing data.Keywords
This publication has 100 references indexed in Scilit:
- Lymphocytic Colitis Treated with Proctocolectomy and Ileal J-Pouch-Anal AnastomosisDiseases of the Colon & Rectum, 2002
- Role of bile acids and bile acid binding agents in patients with collagenous colitisGut, 2000
- Colonic Epithelial Lymphocytosis Associated with an Epidemic of Chronic DiarrheaThe American Journal of Surgical Pathology, 1996
- Autoantibodies and immunoglobulins in collagenous colitis.Gut, 1996
- Faecal stream diversion in patients with collagenous colitis.Gut, 1996
- Drug induced lymphocytic colitis.Gut, 1994
- Microscopic colitis cases revisitedGastroenterology, 1993
- Increased HLA A1 and diminished HLA A3 in lymphocytic colitis compared to controls and patients with collagenous colitisDigestive Diseases and Sciences, 1992
- Collagenous colitis with involvement of terminal ileumDigestive Diseases and Sciences, 1991
- Collagenous colitis pathophysiologic considerationsDigestive Diseases and Sciences, 1991